FierceBiotech Sits Down With H1

Biopharma companies don’t want to go to market with a product no one knows about. H1 has homed in on the often time-consuming research and engagement phases that companies must ace for a successful launch, said Ariel Katz, co-founder of…

FierceBiotech Sits Down With H1

Source

0
(0)

Biopharma companies don’t want to go to market with a product no one knows about. H1 has homed in on the often time-consuming research and engagement phases that companies must ace for a successful launch, said Ariel Katz, co-founder of H1.

Katz recently sat down with FierceBiotech Publisher Rebecca Willumson to discuss challenges and solutions in the space, as well as a newly launched social media tool that brings even more data to H1’s offering.

0 / 5. 0